nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—Levothyroxine—hypothyroidism	0.101	0.28	CbGbCtD
Flurazepam—ABCB1—Liothyronine—hypothyroidism	0.101	0.28	CbGbCtD
Flurazepam—ABCB1—Liotrix—hypothyroidism	0.099	0.273	CbGbCtD
Flurazepam—CYP3A4—Levothyroxine—hypothyroidism	0.0608	0.168	CbGbCtD
Flurazepam—GABRQ—nerve—hypothyroidism	0.017	0.0908	CbGeAlD
Flurazepam—GABRR3—nerve—hypothyroidism	0.017	0.0908	CbGeAlD
Flurazepam—GABRR2—nerve—hypothyroidism	0.0148	0.0788	CbGeAlD
Flurazepam—GABRR1—nerve—hypothyroidism	0.0142	0.0758	CbGeAlD
Flurazepam—Coma—Dextrothyroxine—hypothyroidism	0.0104	0.027	CcSEcCtD
Flurazepam—Coma—Levothyroxine—hypothyroidism	0.0104	0.027	CcSEcCtD
Flurazepam—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00995	0.0258	CcSEcCtD
Flurazepam—Hyperkinesia—Levothyroxine—hypothyroidism	0.00995	0.0258	CcSEcCtD
Flurazepam—Disorientation—Levothyroxine—hypothyroidism	0.00926	0.024	CcSEcCtD
Flurazepam—Disorientation—Dextrothyroxine—hypothyroidism	0.00926	0.024	CcSEcCtD
Flurazepam—Irritability—Dextrothyroxine—hypothyroidism	0.00791	0.0205	CcSEcCtD
Flurazepam—Irritability—Levothyroxine—hypothyroidism	0.00791	0.0205	CcSEcCtD
Flurazepam—Hypotension—Liothyronine—hypothyroidism	0.00775	0.0201	CcSEcCtD
Flurazepam—Coma—Liotrix—hypothyroidism	0.00767	0.0199	CcSEcCtD
Flurazepam—Lightheadedness—Liotrix—hypothyroidism	0.00751	0.0195	CcSEcCtD
Flurazepam—Hyperkinesia—Liotrix—hypothyroidism	0.00732	0.019	CcSEcCtD
Flurazepam—Disorientation—Liotrix—hypothyroidism	0.00681	0.0177	CcSEcCtD
Flurazepam—CYP2E1—urine—hypothyroidism	0.00617	0.0329	CbGeAlD
Flurazepam—Sweating—Levothyroxine—hypothyroidism	0.00612	0.0159	CcSEcCtD
Flurazepam—Sweating—Dextrothyroxine—hypothyroidism	0.00612	0.0159	CcSEcCtD
Flurazepam—Irritability—Liotrix—hypothyroidism	0.00582	0.0151	CcSEcCtD
Flurazepam—Flushing—Dextrothyroxine—hypothyroidism	0.00532	0.0138	CcSEcCtD
Flurazepam—Flushing—Levothyroxine—hypothyroidism	0.00532	0.0138	CcSEcCtD
Flurazepam—CYP3A4—urine—hypothyroidism	0.00496	0.0264	CbGeAlD
Flurazepam—Tension—Dextrothyroxine—hypothyroidism	0.0049	0.0127	CcSEcCtD
Flurazepam—Tension—Levothyroxine—hypothyroidism	0.0049	0.0127	CcSEcCtD
Flurazepam—Nervousness—Dextrothyroxine—hypothyroidism	0.00485	0.0126	CcSEcCtD
Flurazepam—Nervousness—Levothyroxine—hypothyroidism	0.00485	0.0126	CcSEcCtD
Flurazepam—GABRG3—pituitary gland—hypothyroidism	0.00463	0.0247	CbGeAlD
Flurazepam—Agitation—Levothyroxine—hypothyroidism	0.00458	0.0119	CcSEcCtD
Flurazepam—Agitation—Dextrothyroxine—hypothyroidism	0.00458	0.0119	CcSEcCtD
Flurazepam—Sweating—Liotrix—hypothyroidism	0.0045	0.0117	CcSEcCtD
Flurazepam—Palpitations—Levothyroxine—hypothyroidism	0.00441	0.0114	CcSEcCtD
Flurazepam—Palpitations—Dextrothyroxine—hypothyroidism	0.00441	0.0114	CcSEcCtD
Flurazepam—Arthralgia—Dextrothyroxine—hypothyroidism	0.00425	0.011	CcSEcCtD
Flurazepam—Arthralgia—Levothyroxine—hypothyroidism	0.00425	0.011	CcSEcCtD
Flurazepam—Anxiety—Dextrothyroxine—hypothyroidism	0.00423	0.011	CcSEcCtD
Flurazepam—Anxiety—Levothyroxine—hypothyroidism	0.00423	0.011	CcSEcCtD
Flurazepam—Confusional state—Dextrothyroxine—hypothyroidism	0.00411	0.0106	CcSEcCtD
Flurazepam—Confusional state—Levothyroxine—hypothyroidism	0.00411	0.0106	CcSEcCtD
Flurazepam—Shock—Levothyroxine—hypothyroidism	0.00401	0.0104	CcSEcCtD
Flurazepam—Shock—Dextrothyroxine—hypothyroidism	0.00401	0.0104	CcSEcCtD
Flurazepam—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00394	0.0102	CcSEcCtD
Flurazepam—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00394	0.0102	CcSEcCtD
Flurazepam—Flushing—Liotrix—hypothyroidism	0.00391	0.0101	CcSEcCtD
Flurazepam—GABRA4—heart—hypothyroidism	0.00387	0.0206	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00371	0.00962	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00371	0.00962	CcSEcCtD
Flurazepam—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00363	0.00941	CcSEcCtD
Flurazepam—Dyspnoea—Levothyroxine—hypothyroidism	0.00363	0.00941	CcSEcCtD
Flurazepam—Tension—Liotrix—hypothyroidism	0.0036	0.00933	CcSEcCtD
Flurazepam—Dysgeusia—Liotrix—hypothyroidism	0.00359	0.00932	CcSEcCtD
Flurazepam—GABRB1—pituitary gland—hypothyroidism	0.00358	0.0191	CbGeAlD
Flurazepam—Nervousness—Liotrix—hypothyroidism	0.00356	0.00924	CcSEcCtD
Flurazepam—Vision blurred—Liotrix—hypothyroidism	0.00346	0.00897	CcSEcCtD
Flurazepam—GABRG3—testis—hypothyroidism	0.00342	0.0182	CbGeAlD
Flurazepam—Agitation—Liotrix—hypothyroidism	0.00337	0.00874	CcSEcCtD
Flurazepam—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00336	0.0087	CcSEcCtD
Flurazepam—Feeling abnormal—Levothyroxine—hypothyroidism	0.00336	0.0087	CcSEcCtD
Flurazepam—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00333	0.00863	CcSEcCtD
Flurazepam—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00333	0.00863	CcSEcCtD
Flurazepam—Syncope—Liotrix—hypothyroidism	0.00329	0.00853	CcSEcCtD
Flurazepam—GABRR1—testis—hypothyroidism	0.00326	0.0174	CbGeAlD
Flurazepam—Palpitations—Liotrix—hypothyroidism	0.00324	0.00841	CcSEcCtD
Flurazepam—GABRA4—pituitary gland—hypothyroidism	0.00323	0.0172	CbGeAlD
Flurazepam—Loss of consciousness—Liotrix—hypothyroidism	0.00323	0.00836	CcSEcCtD
Flurazepam—GABRP—pituitary gland—hypothyroidism	0.00321	0.0171	CbGeAlD
Flurazepam—GABRR2—cerebellum—hypothyroidism	0.00313	0.0167	CbGeAlD
Flurazepam—Chest pain—Liotrix—hypothyroidism	0.00312	0.0081	CcSEcCtD
Flurazepam—Arthralgia—Liotrix—hypothyroidism	0.00312	0.0081	CcSEcCtD
Flurazepam—Anxiety—Liotrix—hypothyroidism	0.00311	0.00807	CcSEcCtD
Flurazepam—Confusional state—Liotrix—hypothyroidism	0.00302	0.00783	CcSEcCtD
Flurazepam—Anaphylactic shock—Liotrix—hypothyroidism	0.00299	0.00776	CcSEcCtD
Flurazepam—Shock—Liotrix—hypothyroidism	0.00295	0.00764	CcSEcCtD
Flurazepam—GABRE—heart—hypothyroidism	0.00293	0.0156	CbGeAlD
Flurazepam—Asthenia—Levothyroxine—hypothyroidism	0.00292	0.00757	CcSEcCtD
Flurazepam—Asthenia—Dextrothyroxine—hypothyroidism	0.00292	0.00757	CcSEcCtD
Flurazepam—Hyperhidrosis—Liotrix—hypothyroidism	0.0029	0.00751	CcSEcCtD
Flurazepam—Pruritus—Dextrothyroxine—hypothyroidism	0.00288	0.00747	CcSEcCtD
Flurazepam—Pruritus—Levothyroxine—hypothyroidism	0.00288	0.00747	CcSEcCtD
Flurazepam—GABRA3—thyroid gland—hypothyroidism	0.00286	0.0152	CbGeAlD
Flurazepam—Anorexia—Liotrix—hypothyroidism	0.00285	0.0074	CcSEcCtD
Flurazepam—GABRD—testis—hypothyroidism	0.00283	0.0151	CbGeAlD
Flurazepam—Hypotension—Liotrix—hypothyroidism	0.0028	0.00725	CcSEcCtD
Flurazepam—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00279	0.00722	CcSEcCtD
Flurazepam—Diarrhoea—Levothyroxine—hypothyroidism	0.00279	0.00722	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00273	0.00707	CcSEcCtD
Flurazepam—GABRG2—pituitary gland—hypothyroidism	0.0027	0.0144	CbGeAlD
Flurazepam—Dyspnoea—Liotrix—hypothyroidism	0.00267	0.00692	CcSEcCtD
Flurazepam—GABRA5—testis—hypothyroidism	0.00263	0.014	CbGeAlD
Flurazepam—GABRD—cerebellum—hypothyroidism	0.00262	0.0139	CbGeAlD
Flurazepam—Decreased appetite—Liotrix—hypothyroidism	0.0026	0.00675	CcSEcCtD
Flurazepam—Vomiting—Dextrothyroxine—hypothyroidism	0.00259	0.00671	CcSEcCtD
Flurazepam—Vomiting—Levothyroxine—hypothyroidism	0.00259	0.00671	CcSEcCtD
Flurazepam—Rash—Levothyroxine—hypothyroidism	0.00257	0.00665	CcSEcCtD
Flurazepam—Rash—Dextrothyroxine—hypothyroidism	0.00257	0.00665	CcSEcCtD
Flurazepam—Dermatitis—Levothyroxine—hypothyroidism	0.00256	0.00665	CcSEcCtD
Flurazepam—Dermatitis—Dextrothyroxine—hypothyroidism	0.00256	0.00665	CcSEcCtD
Flurazepam—Constipation—Liotrix—hypothyroidism	0.00256	0.00664	CcSEcCtD
Flurazepam—Headache—Levothyroxine—hypothyroidism	0.00255	0.00661	CcSEcCtD
Flurazepam—Headache—Dextrothyroxine—hypothyroidism	0.00255	0.00661	CcSEcCtD
Flurazepam—GABRG1—cerebellum—hypothyroidism	0.00252	0.0134	CbGeAlD
Flurazepam—GABRA6—cerebellum—hypothyroidism	0.0025	0.0133	CbGeAlD
Flurazepam—GABRB3—heart—hypothyroidism	0.00248	0.0132	CbGeAlD
Flurazepam—Feeling abnormal—Liotrix—hypothyroidism	0.00247	0.0064	CcSEcCtD
Flurazepam—Gastrointestinal pain—Liotrix—hypothyroidism	0.00245	0.00635	CcSEcCtD
Flurazepam—GABRA3—testis—hypothyroidism	0.00245	0.013	CbGeAlD
Flurazepam—GABRE—pituitary gland—hypothyroidism	0.00245	0.013	CbGeAlD
Flurazepam—GABRB1—cerebellum—hypothyroidism	0.00244	0.013	CbGeAlD
Flurazepam—Nausea—Dextrothyroxine—hypothyroidism	0.00242	0.00627	CcSEcCtD
Flurazepam—Nausea—Levothyroxine—hypothyroidism	0.00242	0.00627	CcSEcCtD
Flurazepam—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00226	0.0353	CbGpPWpGaD
Flurazepam—GABRA2—adrenal gland—hypothyroidism	0.00221	0.0118	CbGeAlD
Flurazepam—GABRA4—cerebellum—hypothyroidism	0.0022	0.0117	CbGeAlD
Flurazepam—GABRE—adrenal gland—hypothyroidism	0.00219	0.0117	CbGeAlD
Flurazepam—Asthenia—Liotrix—hypothyroidism	0.00215	0.00557	CcSEcCtD
Flurazepam—GABRB3—gonad—hypothyroidism	0.00213	0.0113	CbGeAlD
Flurazepam—Pruritus—Liotrix—hypothyroidism	0.00212	0.00549	CcSEcCtD
Flurazepam—GABRE—thyroid gland—hypothyroidism	0.00211	0.0112	CbGeAlD
Flurazepam—GABRB3—pituitary gland—hypothyroidism	0.00207	0.0111	CbGeAlD
Flurazepam—Diarrhoea—Liotrix—hypothyroidism	0.00205	0.00531	CcSEcCtD
Flurazepam—GABRE—female gonad—hypothyroidism	0.00204	0.0109	CbGeAlD
Flurazepam—GABRB2—testis—hypothyroidism	0.002	0.0106	CbGeAlD
Flurazepam—Dizziness—Liotrix—hypothyroidism	0.00198	0.00513	CcSEcCtD
Flurazepam—CYP2A6—liver—hypothyroidism	0.00195	0.0104	CbGeAlD
Flurazepam—CYP2A6—cerebellum—hypothyroidism	0.00191	0.0102	CbGeAlD
Flurazepam—Vomiting—Liotrix—hypothyroidism	0.0019	0.00494	CcSEcCtD
Flurazepam—Rash—Liotrix—hypothyroidism	0.00189	0.0049	CcSEcCtD
Flurazepam—Dermatitis—Liotrix—hypothyroidism	0.00189	0.00489	CcSEcCtD
Flurazepam—Headache—Liotrix—hypothyroidism	0.00188	0.00486	CcSEcCtD
Flurazepam—GABRB2—cerebellum—hypothyroidism	0.00184	0.00982	CbGeAlD
Flurazepam—GABRG2—cerebellum—hypothyroidism	0.00184	0.00982	CbGeAlD
Flurazepam—GABRE—testis—hypothyroidism	0.00181	0.00964	CbGeAlD
Flurazepam—GABRB3—thyroid gland—hypothyroidism	0.00179	0.00953	CbGeAlD
Flurazepam—Nausea—Liotrix—hypothyroidism	0.00178	0.00461	CcSEcCtD
Flurazepam—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00172	0.027	CbGpPWpGaD
Flurazepam—GABRA2—cerebellum—hypothyroidism	0.00168	0.00898	CbGeAlD
Flurazepam—GABRA1—cerebellum—hypothyroidism	0.00163	0.00868	CbGeAlD
Flurazepam—GABRB3—testis—hypothyroidism	0.00153	0.00817	CbGeAlD
Flurazepam—CYP2E1—cardiovascular system—hypothyroidism	0.00149	0.00795	CbGeAlD
Flurazepam—GABRB3—liver—hypothyroidism	0.00145	0.00772	CbGeAlD
Flurazepam—GABRB3—cerebellum—hypothyroidism	0.00142	0.00754	CbGeAlD
Flurazepam—CYP2E1—adrenal gland—hypothyroidism	0.00118	0.00628	CbGeAlD
Flurazepam—CYP2E1—blood—hypothyroidism	0.00118	0.00628	CbGeAlD
Flurazepam—CYP2E1—thyroid gland—hypothyroidism	0.00114	0.00606	CbGeAlD
Flurazepam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00102	0.0159	CbGpPWpGaD
Flurazepam—CYP2E1—testis—hypothyroidism	0.000975	0.0052	CbGeAlD
Flurazepam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000973	0.0152	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000973	0.0152	CbGpPWpGaD
Flurazepam—CYP3A4—blood—hypothyroidism	0.000949	0.00506	CbGeAlD
Flurazepam—ABCB1—adrenal cortex—hypothyroidism	0.00093	0.00496	CbGeAlD
Flurazepam—CYP2E1—liver—hypothyroidism	0.000922	0.00491	CbGeAlD
Flurazepam—CYP2E1—cerebellum—hypothyroidism	0.000901	0.0048	CbGeAlD
Flurazepam—ABCB1—heart—hypothyroidism	0.0009	0.0048	CbGeAlD
Flurazepam—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000883	0.0138	CbGpPWpGaD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000874	0.0137	CbGpPWpGaD
Flurazepam—ABCB1—cardiovascular system—hypothyroidism	0.000849	0.00453	CbGeAlD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000834	0.013	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000834	0.013	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000807	0.0126	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000801	0.0125	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000789	0.0123	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.000781	0.0122	CbGpPWpGaD
Flurazepam—ABCB1—gonad—hypothyroidism	0.000771	0.00411	CbGeAlD
Flurazepam—ABCB1—pituitary gland—hypothyroidism	0.000752	0.00401	CbGeAlD
Flurazepam—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000747	0.0117	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—SLC5A7—hypothyroidism	0.000745	0.0116	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.000745	0.0116	CbGpPWpGaD
Flurazepam—CYP3A4—liver—hypothyroidism	0.000742	0.00395	CbGeAlD
Flurazepam—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000737	0.0115	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000687	0.0107	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000676	0.0106	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000674	0.0105	CbGpPWpGaD
Flurazepam—ABCB1—adrenal gland—hypothyroidism	0.000672	0.00358	CbGeAlD
Flurazepam—ABCB1—blood—hypothyroidism	0.000671	0.00358	CbGeAlD
Flurazepam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000657	0.0103	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000655	0.0102	CbGpPWpGaD
Flurazepam—ABCB1—thyroid gland—hypothyroidism	0.000648	0.00345	CbGeAlD
Flurazepam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000643	0.0101	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00064	0.01	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000632	0.00988	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000632	0.00988	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000628	0.00981	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000627	0.0098	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000627	0.0098	CbGpPWpGaD
Flurazepam—ABCB1—female gonad—hypothyroidism	0.000626	0.00334	CbGeAlD
Flurazepam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000617	0.00964	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.000614	0.00959	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.000605	0.00945	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.000584	0.00913	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000578	0.00903	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.000572	0.00894	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.000565	0.00883	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000562	0.00877	CbGpPWpGaD
Flurazepam—ABCB1—testis—hypothyroidism	0.000555	0.00296	CbGeAlD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000551	0.00862	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000542	0.00847	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000539	0.00842	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000538	0.00841	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000529	0.00826	CbGpPWpGaD
Flurazepam—ABCB1—liver—hypothyroidism	0.000525	0.0028	CbGeAlD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00052	0.00812	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000517	0.00807	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000516	0.00807	CbGpPWpGaD
Flurazepam—ABCB1—cerebellum—hypothyroidism	0.000513	0.00273	CbGeAlD
Flurazepam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000509	0.00795	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.000503	0.00787	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.000502	0.00784	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000495	0.00773	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000493	0.0077	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000484	0.00757	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.000481	0.00752	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000481	0.00752	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—NEFL—hypothyroidism	0.00048	0.00751	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.00048	0.00751	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000475	0.00742	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000473	0.00738	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000462	0.00722	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000435	0.00679	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000422	0.0066	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00042	0.00656	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000415	0.00648	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000413	0.00645	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000407	0.00637	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000405	0.00632	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000401	0.00627	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000401	0.00626	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000401	0.00626	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000397	0.00621	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000396	0.00618	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.00039	0.00609	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000379	0.00593	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000369	0.00576	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000364	0.00569	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000348	0.00544	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000347	0.00543	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000333	0.0052	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000332	0.0052	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000332	0.00519	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000332	0.00519	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00033	0.00516	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000325	0.00508	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000323	0.00505	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000319	0.00498	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000318	0.00496	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000312	0.00488	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.00031	0.00485	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000308	0.00481	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000305	0.00476	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000304	0.00475	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000278	0.00434	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000273	0.00427	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00027	0.00422	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000269	0.00421	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000267	0.00417	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000266	0.00416	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000265	0.00414	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00026	0.00407	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000259	0.00404	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000255	0.00398	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000254	0.00397	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000252	0.00393	CbGpPWpGaD
Flurazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000249	0.00389	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000244	0.00382	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	0.000234	0.00365	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00023	0.0036	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000224	0.00349	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000222	0.00347	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00022	0.00343	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000216	0.00337	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000214	0.00335	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000211	0.00329	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000207	0.00323	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000204	0.00319	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000202	0.00315	CbGpPWpGaD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000197	0.00307	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000184	0.00288	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000169	0.00264	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000168	0.00262	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00016	0.00251	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00016	0.0025	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00016	0.0025	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000159	0.00249	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—IYD—hypothyroidism	0.000138	0.00215	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000132	0.00207	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000132	0.00206	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00013	0.00203	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—IYD—hypothyroidism	0.000126	0.00198	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000126	0.00197	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000126	0.00197	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000126	0.00197	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000123	0.00192	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000121	0.0019	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000117	0.00183	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000111	0.00174	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000111	0.00174	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TPO—hypothyroidism	0.00011	0.00172	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000108	0.00169	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ATP5O—hypothyroidism	0.000108	0.00168	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—POMC—hypothyroidism	0.000107	0.00168	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000106	0.00166	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000104	0.00163	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000104	0.00162	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000103	0.00162	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000102	0.0016	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000102	0.00159	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TPO—hypothyroidism	0.000101	0.00158	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—IYD—hypothyroidism	9.99e-05	0.00156	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	9.68e-05	0.00151	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	9.56e-05	0.00149	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.23e-05	0.00144	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.13e-05	0.00143	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.88e-05	0.00139	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	8.74e-05	0.00137	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ATP5O—hypothyroidism	8.5e-05	0.00133	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	8.49e-05	0.00133	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—POMC—hypothyroidism	8.47e-05	0.00132	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	8.34e-05	0.0013	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	8.2e-05	0.00128	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.15e-05	0.00127	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	8.14e-05	0.00127	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	8e-05	0.00125	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TPO—hypothyroidism	7.99e-05	0.00125	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—IYD—hypothyroidism	7.53e-05	0.00118	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.4e-05	0.00116	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.99e-05	0.00109	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.42e-05	0.001	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ATP5O—hypothyroidism	6.4e-05	0.001	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TPO—hypothyroidism	6.02e-05	0.00094	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.64e-05	0.000882	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TSHB—hypothyroidism	5.1e-05	0.000797	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TSHB—hypothyroidism	4.68e-05	0.000731	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—IYD—hypothyroidism	4.64e-05	0.000725	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	4.54e-05	0.00071	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.45e-05	0.000696	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	4.17e-05	0.000652	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.94e-05	0.000616	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.93e-05	0.000614	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC5A5—hypothyroidism	3.82e-05	0.000596	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TPO—hypothyroidism	3.71e-05	0.000579	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TSHB—hypothyroidism	3.7e-05	0.000578	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.51e-05	0.000548	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC5A5—hypothyroidism	3.5e-05	0.000548	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	3.3e-05	0.000515	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TSHB—hypothyroidism	2.79e-05	0.000435	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC5A5—hypothyroidism	2.77e-05	0.000433	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.48e-05	0.000388	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.09e-05	0.000326	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—POMC—hypothyroidism	2e-05	0.000312	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—POMC—hypothyroidism	1.83e-05	0.000286	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TSHB—hypothyroidism	1.72e-05	0.000268	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.53e-05	0.000239	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—POMC—hypothyroidism	1.45e-05	0.000226	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.28e-05	0.000201	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—POMC—hypothyroidism	1.09e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—POMC—hypothyroidism	6.72e-06	0.000105	CbGpPWpGaD
